degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatiske neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
mifepriston "linepharma" 200 mg tabletter
linepharma international limited - mifepriston - tabletter - 200 mg
neulactil 10 mg tabletter
sanofi a/s - periciazin - tabletter - 10 mg
neulactil 2,5 mg tabletter
sanofi a/s - periciazin - tabletter - 2,5 mg
bicalutamid "bluefish" 50 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - bicalutamid - filmovertrukne tabletter - 50 mg
bicalutamid "sandoz" 150 mg filmovertrukne tabletter
sandoz a/s - bicalutamid - filmovertrukne tabletter - 150 mg
spiron 50 mg tabletter
orion corporation - spironolacton - tabletter - 50 mg
bicalutamid "bluefish" 150 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - bicalutamid - filmovertrukne tabletter - 150 mg
bicalutamide "teva" 150 mg filmovertrukne tabletter
teva b.v. - bicalutamid - filmovertrukne tabletter - 150 mg
bicalutamide "teva" 50 mg filmovertrukne tabletter
teva b.v. - bicalutamid - filmovertrukne tabletter - 50 mg